Search

Author/Creator Peraire, J

2. Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort2. Issue 3 (27th January 2019)

Authors:
Llibre, JM; Montoliu, A; Miró, JM; Domingo, P; Riera, M; Tiraboschi, J; Curran, A; Homar, F; Ambrosioni, J; Abdulghani, N; Force, L; Peraire, J; Casabona, J
Other Names:
Vilaró Joaquim investigator.; Masabeu Angels investigator.; Orti Amat J. investigator.; Dalmau David investigator.; Reyes Juliana investigator.; Bruguera Andreu investigator.; Montoliu Alexandra investigator.; Muntada Esteve investigator.; Podzamczer D. investigator.; Navarro G. investigator.; Co...
Journal:
HIV medicine
Issue:
Volume 20:Issue 3(2019)
Page Start:
237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir. Issue 6 (12th January 2014)

Authors:
Martinez, E; Gonzalez‐Cordon, A; Ferrer, E; Domingo, P; Negredo, E; Gutierrez, F; Portilla, J; Curran, A; Podzamczer, D; Murillas, J; Bernardino, JI; Santos, I; Carton, JA; Peraire, J; Pich, J; Perez, I; Gatell, JM; ATADAR Study Group
Journal:
HIV medicine
Issue:
Volume 15:Issue 6(2014:Jul.)
Page Start:
330
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗